Description
GHRP-2 and Ipamorelin are synthetic research peptides commonly used together in experimental models to investigate growth hormone axis regulation and pituitary receptor signaling. GHRP-2 is a potent hexapeptide growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R1a), stimulating Gq/PLC-dependent calcium signaling involved in GH release and endocrine feedback mechanisms. Ipamorelin is a selective pentapeptide GHS-R1a agonist that promotes GH secretion through calcium-mediated pathways while demonstrating minimal interaction with other pituitary hormone systems in preclinical studies. The combined use of these peptides in research settings allows for the investigation of complementary GHS-R1a signaling dynamics, receptor pharmacology, and somatotropic pathway modulation.
For research use only. Not for human consumption.
References:
Bowers CY et al., Ann NY Acad Sci, 1998 865:244–249
Jacks T et al., Endocrinology, 1994 134(2):744–750
Svensson J et al., J Endocrinol Invest, 1998 21(9):692–699
Reviews
There are no reviews yet.